Dagmar Bury

808 total citations
18 papers, 466 citations indexed

About

Dagmar Bury is a scholar working on Dermatology, Small Animals and Health, Toxicology and Mutagenesis. According to data from OpenAlex, Dagmar Bury has authored 18 papers receiving a total of 466 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Dermatology, 8 papers in Small Animals and 7 papers in Health, Toxicology and Mutagenesis. Recurrent topics in Dagmar Bury's work include Contact Dermatitis and Allergies (10 papers), Animal testing and alternatives (8 papers) and Effects and risks of endocrine disrupting chemicals (6 papers). Dagmar Bury is often cited by papers focused on Contact Dermatitis and Allergies (10 papers), Animal testing and alternatives (8 papers) and Effects and risks of endocrine disrupting chemicals (6 papers). Dagmar Bury collaborates with scholars based in France, Germany and United Kingdom. Dagmar Bury's co-authors include Werner Schmidt, K. Ziegler-Skylakakis, H.-J. Klimisch, Helmut Greim, Nathalie Alépée, Erwin van Vliet, Martina Klarić, F. Gautier, Werner Schuh and Klaus Rettinger and has published in prestigious journals such as Chemosphere, Life Sciences and Food and Chemical Toxicology.

In The Last Decade

Dagmar Bury

18 papers receiving 446 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Dagmar Bury France 10 123 99 84 62 50 18 466
Hao Ou‐Yang United States 11 318 2.6× 21 0.2× 77 0.9× 15 0.2× 58 1.2× 21 510
Nadim A. Shaath United States 6 369 3.0× 21 0.2× 91 1.1× 4 0.1× 43 0.9× 12 573
Jan Sollenberg Sweden 11 55 0.4× 8 0.1× 131 1.6× 47 0.8× 96 1.9× 26 439
Norbert Groth Germany 17 497 4.0× 10 0.1× 27 0.3× 6 0.1× 132 2.6× 34 927
Marloes J.A. Joosen Netherlands 15 13 0.1× 12 0.1× 59 0.7× 79 1.3× 51 1.0× 32 510
Thomas G. Polefka United States 12 243 2.0× 4 0.0× 66 0.8× 6 0.1× 121 2.4× 22 541
Cátia Silva Portugal 7 9 0.1× 8 0.1× 31 0.4× 15 0.2× 129 2.6× 10 435
T. Herrling Germany 11 262 2.1× 4 0.0× 31 0.4× 4 0.1× 89 1.8× 25 527
Óscar Jiménez Spain 12 112 0.9× 6 0.1× 19 0.2× 15 0.2× 137 2.7× 19 532
Barathi Seetharaman India 10 6 0.0× 14 0.1× 329 3.9× 18 0.3× 102 2.0× 23 700

Countries citing papers authored by Dagmar Bury

Since Specialization
Citations

This map shows the geographic impact of Dagmar Bury's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dagmar Bury with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dagmar Bury more than expected).

Fields of papers citing papers by Dagmar Bury

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dagmar Bury. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dagmar Bury. The network helps show where Dagmar Bury may publish in the future.

Co-authorship network of co-authors of Dagmar Bury

This figure shows the co-authorship network connecting the top 25 collaborators of Dagmar Bury. A scholar is included among the top collaborators of Dagmar Bury based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dagmar Bury. Dagmar Bury is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Bury, Dagmar, et al.. (2025). Case studies using the probabilistic aggregate consumer exposure model (PACEM) for cosmetics ingredient safety assessment. Regulatory Toxicology and Pharmacology. 161. 105836–105836. 1 indexed citations
2.
Vliet, Erwin van, et al.. (2023). Skin sensitisation prediction using read-across, an illustrative next generation risk assessment (NGRA) case study for vanillin. Regulatory Toxicology and Pharmacology. 143. 105458–105458. 3 indexed citations
3.
Tozer, S., F. Audebert, John O’Brien, et al.. (2023). From worst-case to reality – Case studies illustrating tiered refinement of consumer exposure to cosmetic ingredients. Regulatory Toxicology and Pharmacology. 143. 105436–105436. 3 indexed citations
4.
Escher, Sylvia E., Jane Rose, N. Sadekar, et al.. (2023). Workshop report: Challenges faced in developing inhalation thresholds of Toxicological Concern (TTC) - State of the science and next steps. Regulatory Toxicology and Pharmacology. 142. 105434–105434. 2 indexed citations
5.
Hoffmann, Sebastian, Nathalie Alépée, N. Gilmour, et al.. (2022). Expansion of the Cosmetics Europe skin sensitisation database with new substances and PPRA data. Regulatory Toxicology and Pharmacology. 131. 105169–105169. 16 indexed citations
6.
Westerhout, Joost, Robert Rißmann, Jacobus Burggraaf, et al.. (2022). Assessment of dermal absorption of aluminium from a representative antiperspirant formulation using a (26Al)Al microtracer approach: a follow-up study in humans. Toxicology Research. 11(3). 511–519. 4 indexed citations
7.
Bury, Dagmar, Harvey J. Clewell, M Cronin, et al.. (2021). New framework for a non-animal approach adequately assures the safety of cosmetic ingredients – A case study on caffeine. Regulatory Toxicology and Pharmacology. 123. 104931–104931. 32 indexed citations
8.
Gautier, F., et al.. (2021). Next generation risk assessment for skin sensitisation: A case study with propyl paraben. Regulatory Toxicology and Pharmacology. 123. 104936–104936. 19 indexed citations
9.
Bury, Dagmar, et al.. (2021). The Threshold of Toxicological Concern (TTC) is a pragmatic tool for the safety assessment: Case studies of cosmetic ingredients with low consumer exposure. Regulatory Toxicology and Pharmacology. 123. 104964–104964. 6 indexed citations
10.
Gilmour, N., Petra Kern, Nathalie Alépée, et al.. (2020). Development of a next generation risk assessment framework for the evaluation of skin sensitisation of cosmetic ingredients. Regulatory Toxicology and Pharmacology. 116. 104721–104721. 64 indexed citations
11.
Gautier, F., et al.. (2020). Read-across can increase confidence in the Next Generation Risk Assessment for skin sensitisation: A case study with resorcinol. Regulatory Toxicology and Pharmacology. 117. 104755–104755. 27 indexed citations
12.
13.
Petry, Thomas, Dagmar Bury, Rolf Fautz, et al.. (2017). Review of data on the dermal penetration of mineral oils and waxes used in cosmetic applications. Toxicology Letters. 280. 70–78. 62 indexed citations
14.
Greim, Helmut, et al.. (1998). Toxicity of aliphatic amines: Structure-activity relationship. Chemosphere. 36(2). 271–295. 135 indexed citations
15.
Pauluhn, J., et al.. (1996). Acute inhalation toxicity testing: considerations of technical and regulatory aspects. Archives of Toxicology. 71(1-2). 1–10. 10 indexed citations
16.
Allen, Sandra L., W. Classen, Dagmar Bury, et al.. (1994). Evaluation of the neurotoxic potential of chemicals in animals. Food and Chemical Toxicology. 32(7). 655–669. 9 indexed citations
17.
Schmidt, Werner & Dagmar Bury. (1988). Behavioural effects of N-methyl-D-aspartate in the anterodorsal striatum of the rat. Life Sciences. 43(6). 545–549. 55 indexed citations
18.
Bury, Dagmar & Werner Schmidt. (1987). Effects of systemically and intrastriatally injected haloperidol and apomorphine on grooming, feeding and locomotion in the rat. Behavioural Processes. 15(2-3). 269–283. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026